In July, a phase III trial study conducted by Swiss biotech firm Roche suggested that the drug “did not demonstrate a benefit for patients in either clinical status or mortality”.
Doctors in Delhi cut down on arthritis drug being used in coronavirus treatment
Tweet on Twitter
Share on Facebook
Google+
Pinterest
